Bo Ren
- Molecular Biology
- Oncology top 10%
- Cancer Research top 10%
- Immunology
- Pulmonary and Respiratory Medicine
- Topics
- Microbial Natural Products and Biosynthesis (2 papers)Computational Drug Discovery Methods (2 papers)Multicomponent Synthesis of Heterocycles (2 papers)
- Cited by
- Cancer ResearchOncologyImmunology
- Journals
- PLoS ONEMoleculesMolecular Cancer
- Partner nations
- ChinaUnited KingdomHong Kong
In The Last Decade
Bo Ren
16 papers receiving 721 citations
Hit Papers
Peers
Comparison fields: 5 of 73
- Molecular Biology 287
- Oncology 274
- Cancer Research 174
- Immunology 130
- Pulmonary and Respiratory Medicine 85
Countries citing papers authored by Bo Ren
This map shows the geographic impact of Bo Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Ren more than expected).
Fields of papers citing papers by Bo Ren
This network shows the impact of papers produced by Bo Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Ren. The network helps show where Bo Ren may publish in the future.
Co-authorship network of co-authors of Bo Ren
This figure shows the co-authorship network connecting the top 25 collaborators of Bo Ren. A scholar is included among the top collaborators of Bo Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Ren. Bo Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 46 | |
| 3 | 4 | |
| 4 | 8 | |
| 5 | 38 | |
| 6 | 7 | |
| 7 | 26 | |
| 8 | 11 | |
| 9 | 18 | |
| 10 | 1 | |
| 11 | Tumor microenvironment participates in metastasis of pancreatic cancerbreakdown → | 421 |
| 12 | 9 | |
| 13 | 41 | |
| 14 | 55 | |
| 15 | 22 | |
| 16 | Preventive Effect of Bifidobacterium Tetravaccine Tablets in Premature Infants with Necrotizing Enterocolitis | 15 |
| 17 | Chemical constituents from Hedysarum polybotrys and their antitumor activities | 6 |
About Bo Ren
Bo Ren is a scholar working on Pharmacology, Complementary and alternative medicine and Biotechnology, having authored 17 papers that have together received 728 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (2 papers), Computational Drug Discovery Methods (2 papers) and Multicomponent Synthesis of Heterocycles (2 papers). The work is most often cited by research in Cancer Research (174 citations), Oncology (274 citations) and Immunology (130 citations). Bo Ren has collaborated with scholars based in China, United Kingdom and Hong Kong. Frequent co-authors include Mengyu Feng, Gang Yang, Ming Cui, Yupei Zhao, Lei You, Huanyu Wang, Zhijun Diao, Shaobo Ma, Qinglian Qiao and Yu‐Wei Chen. Their work appears in journals such as PLoS ONE, Molecules and Molecular Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.